| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.0069 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |